Mucin (MUC)1 is a multifunctional mucin expressed by a variety of reproductive tract epithelia. Trophoblast invasion is essential for normal placental development. However, MUC1 expression in the human placenta throughout pregnancy and the role of MUC1 in trophoblast-like cell invasion are still unclear. In the present study, results from quantitative RT-PCR and Western blot demonstrated that MUC1 mRNA and MUC1 protein expression, respectively, increased with gestational age of the human placenta. Immunohistochemistry revealed that MUC1 in placental villi was mainly expressed by syncytiotrophoblasts throughout pregnancy and increased with gestational age. Interestingly, we found two populations of extravillous trophoblasts, MUC1-positive and MUC1-negative cells, in decidua. The numbers of MUC1-positive extravillous trophoblasts were increased during placental development. Furthermore, MUC1 overexpression significantly (P , 0.01) suppressed matrigel invasion of trophoblast-like JAR cells by 34.6% 6 4.5% compared with control, which was associated with a decrease in MMP9 activity assessed by gelatin zymography. Our results suggest that MUC1 expression in the human placenta is increased during placental development, and its overexpression suppresses trophoblast-like cell invasion in vitro.
INTRODUCTION
During placental development, cytotrophoblasts in placental villi differentiate into the extravillous trophoblast and syncytiotrophoblast. Interstitial invasion of the extravillous trophoblast through the endometrial decidua is crucial for successful pregnancy. The primary placental defect in preeclampsia is shallow invasion of the extravillous trophoblast into the decidua, which leads to incomplete spiral artery remodeling and inadequate uteroplacental perfusion [1] . The syncytiotrophoblast covers the chorionic villi and is bathed by maternal blood in the intervillous space. Its primary functions are to remove wastes, exchange oxygen and nutrients, and produce hormones. Its wellcontrolled differentiation and maintenance are also essential for successful pregnancy. It has been found that syncytiotrophoblast microparticles are shed into maternal circulation at higher levels in preeclampsia than normal pregnancy, and this is believed to stimulate systemic inflammatory response and endothelial cell damage in preeclampsia [2, 3] .
Mucins are highly glycosylated proteins expressed by epithelial cells of various organs. They are classified into two classes: secreted mucins and membrane-bound mucins [4] . The secreted gel-forming mucins, which lack a transmembrane domain, include MUC2, MUC5AC, MUC5B, MUC6, MUC7, MUC8, and MUC19. The membrane-bound mucins, which possess a single transmembrane domain and a highly conserved cytoplasmic tail, include MUC1, MUC3A, MUC4, MUC12, MUC13, MUC15, MUC16, MUC17, and MUC20 [4] . These membrane-bound mucins are postulated to serve as sensors of the external environment and can transmit signals into the cell.
In the female reproductive tract, MUC1 is expressed in the uterine epithelium in many species and is believed to regulate embryo attachment via its anti-adhesive or adhesive activity [5] [6] [7] [8] [9] [10] . MUC1 has been found to be expressed by mouse [11] , macaque [12] , and human trophoblasts [13] . MUC1 is suggested to be involved in trophoblast adhesion to uterine endothelial cells and in trophoblast transendothelial migration [12] . In addition to MUC1, significant amounts of MUC3A, MUC15, and MUC20 mRNA have been detected in human term placenta [14, 15] . Recently, we found that MUC15 is expressed by human trophoblasts, and its overexpression suppresses matrigel invasion of choriocarcinoma cell lines JAR and JEG-3 [14] .
Among the known mucins, MUC1 is best studied and plays crucial roles in regulating many cellular properties, including cell proliferation, apoptosis, adhesion, and invasion [4] . Although MUC1 has been found to be expressed by trophoblasts of various species, its expression in the human placenta throughout pregnancy and its potential role in trophoblast invasion remain unclear. In the present study, we therefore investigated MUC1 expression in the human placenta and the effect of MUC1 on the invasion of trophoblast-like JAR cells.
MATERIALS AND METHODS

Antibodies
Mouse anti-MUC1 monoclonal antibodies (mAbs) (clone VU4H5 and M2C5) and mouse anti-cytokeratin (CK)7 (hereafter referred to as KRT7) mAb were purchased from Santa Cruz (California). Mouse anti-b-actin (ACTB) mAb was purchased from BD Pharmingen (California). Goat anti-mouse IgG horseradish peroxidase (HRP)-conjugated secondary antibodies were from Vector Laboratories (California).
Cell Line and Cell Culture
Human choriocarcinoma cell line JAR was purchased from BCRC (Hsinchu, Taiwan). Cells were maintained with Dulbecco modified Eagle medium (DMEM; Biowest, Florida) containing 10% fetal bovine serum (PAA Laboratories, Austria), 100 IU/ml penicillin, and 100 lg/ml streptomycin (Biowest) in a humidified tissue culture incubator at 378C in 5% CO 2 atmosphere.
Clinical Tissue Collection
Human placental tissues from the first trimester (7-12 wk gestation; n ¼ 6), second trimester (17-25 wk gestation; n ¼ 6), and third trimester (36-39 wk gestation; n ¼ 10) were obtained from the Department of Obstetrics and Gynecology, National Taiwan University Hospital. The use of human placentas for this study was approved by the local hospital ethics committee, and written consent was obtained from patients before the collection of samples. The detailed information from patients was listed in Table 1 . The maternal age and mean arterial pressure between patients of different trimesters are not significantly different. The placental tissue sections were obtained by dissecting a 1.5-cm square-shaped segment with a 0.5-cm thickness from the maternal part of placentas. For immunohistochemistry, specimens were fixed in 4% (w/v) paraformaldehyde/ PBS at 48C overnight. For RNA extraction, specimens were soaked in RNAlater (Qiagen, California) at 48C overnight and then stored at À208C. For Western blot analysis, the samples were stored at À808C until use.
RNA Extraction and cDNA Synthesis
Trizol reagent (InVitrogen, California) was used to extract total RNA according to the manufacturer's protocol. Two micrograms of the total RNA were reverse-transcribed into cDNA in a total volume of 25 ll using StrataScript reverse transcriptase (Stratagene, California). A 2-ll aliquot of the cDNA was used for a quantitative PCR reaction.
Quantitative Real-Time PCR
Quantitative PCR system Mx3000P (Stratagene) was used to analyze gene expression in human placentas according to the manufacturer's protocol. Briefly, the reaction was performed in a 25-ll volume consisting of 2 ll cDNA, 400 nM each of sense and anti-sense primers, and 12.5 ll Brilliant SYBR Green QPCR Master Mix (Stratagene). In the reaction, we used the following primer sets. For ACTB (b-actin) detection, the sense and anti-sense primers were 5 0 -GCT CGT CGT CGA CAA CGG CT-3 0 and 5 0 -AAA CAT GAT CTG GGT CAT CTT CT-3 0 , respectively, generating a 326-bp fragment. For human MUC1 detection, the sense and anti-sense primers were 5 0 -CGA TCG TAG CCC CTA TGA GA-3 0 and 5 0 -TGA GCA GCC CAC CTG AAC TC-3 0 , respectively, generating a 220-bp fragment. PCR reactions were incubated at 958C for 15 min, followed by 40 amplification cycles with 30-sec denaturation at 958C, 50-sec annealing at 548C, and 30-sec extension at 728C. Samples were analyzed in triplicate, and product purity was checked through dissociation curves at the end of real-time PCR cycles. PCR products were confirmed to be correct by DNA sequencing. Relative quantity of specific gene expression normalized to ACTB was analyzed with MxPro Software (Stratagene).
Western Blot
Human placental tissues or cells were homogenized in lysis buffer containing 1% (v/v) Triton X-100, 20 mM Tris-HCl (pH 8.0), 160 mM NaCl, 1 mM CaCl 2 , and 1 mM PMSF, followed by ultrasonication (three 5-sec bursts) [16] . Insoluble materials were removed by centrifugation at 10 000 3 g for 15 min at 48C. Forty micrograms of total proteins were separated on a 6% SDS-PAGE and transferred to a Hybond enhanced chemiluminescence nitrocellulose membrane (GE Healthcare, U.K.). MUC1 protein was detected with mouse anti-MUC1 mAbs. ACTB was an internal control and detected with mouse anti-ACTB mAb. Bands were visualized by incubation with anti-mouse HRPconjugated secondary antibodies (Vector Laboratories) and enhanced chemiluminescence reagents (GE Healthcare). The MUC1 signals were quantified and normalized to ACTB signals by the use of ImageQuant 5.1 software (Molecular Dynamics, California).
Immunohistochemistry
Paraffin-embedded human placental sections were deparaffinized in xylene and rehydrated in a series of graded alcohol. After quenching the activity of endogenous peroxidase with 3% (v/v) H 2 O 2 in PBS for 30 min, the sections were rinsed twice with PBS for 10 min and then blocked with 5% (w/v) nonfat milk/PBS for 1 h to reduce nonspecific bindings. Sections were incubated with primary antibodies (1:400 for anti-MUC1 mAb VU4H5; 1:100 for anti-MUC1 mAb M2C5; 1:100 for anti-KRT7 mAb) diluted in 5% (w/v) nonfat milk/PBS for 16 h at 48C. Negative controls were performed by replacing primary antibodies with an isotype-matched control IgG at the same concentration. After rinsing twice with PBS, Super Sensitive Link-Label IHC Detection System (BioGenex, California) was used, and the specific immunostaining was visualized with 3,3-diaminobenzidine liquid substrate system (Sigma, Missouri). All sections were counterstained with hematoxylin for 30 sec and mounted with UltraKitt (J.T. Baker; Deventer, Holland).
Transient Transfection
Cells ( 
Matrigel Invasion Assays
Cell invasion assays were analyzed in a BD Biocoat Matrigel Invasion Chamber (BD Biosciences, Massachusetts) according to the manufacturer's protocol, as described previously [18] . Briefly, cells (1 3 10 5 ) in 500 ll DMEM were added to each chamber and allowed to invade the matrigel for 48 h in a humidified tissue culture incubator at 378C and 5% CO 2 atmosphere. The noninvading cells on the upper surface of the membrane were removed by scrubbing with a cotton-tipped swab, and the invaded cells on the lower surface of the membrane were fixed with 100% methanol and then stained with 0.5% (w/v) crystal violet (Sigma). After two washes with distilled water, the membrane was detached from the chamber, and the number of invaded cells per field was counted under a phase contrast microscope. The means 6 SD were calculated from six different fields per chamber.
Gelatin Zymography
Conditioned media of mock-or MUC1-transfected cells cultured in serumfree DMEM for 48 h were electrophoresed on an 8% SDS-PAGE copolymerized with 1% (w/v) gelatin. After electrophoresis, the gels were washed twice for 30 min in 2.5% (v/v) Triton X-100 and incubated for 16 h in developing buffer (50 mM Tris, 200 mM NaCl, 10 mM CaCl 2 , and 0.05% Brij35; pH 7.5). After incubation, gels were stained with Coomassie Brilliant Blue R-250 (0.5% in 50% methanol and 10% glacial acetic acid; Sigma, St. Louis, MO) for 2 h and destained in 10% (v/v) glacial acetic acid and 20% (v/v) methanol to reveal zones of gelatinase activity.
Statistical Analysis
Student t-test or Mann-Whitney U-test was used for statistical analyses. Data were presented as mean 6 SD. P , 0.05 was considered statistically significant.
RESULTS
MUC1 mRNA Expression in the Human Placenta
Quantitative RT-PCR was performed to detect the expression level of MUC1 mRNA in normal placentas in the first (7-12 wk 
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gestation; n ¼ 6), second (17-25 wk gestation; n ¼ 6), and third (36-39 wk gestation; n ¼ 10) trimester. The results revealed that MUC1 mRNA expression in the third trimester placenta was significantly higher than that in the first (P , 0.01) and second (P , 0.05) trimester placenta (Fig. 1A) . Although MUC1 mRNA expression in the second trimester placenta was higher than that in the first trimester placenta, it was not statistically significant (P ¼ 0.17). Representative amplification plots of the quantitative RT-PCR were shown in Figure 1B . These results indicate that the MUC1 mRNA expression in the human placenta is increased during placental development.
MUC1 Protein Expression in the Human Placenta
To investigate MUC1 protein expression in the human placenta at different gestational stages of pregnancy, Western blotting was performed. Two major bands (170 kDa and .250 kDa) of MUC1 protein were detected by clone VU4H5 of anti-MUC1 mAb in human placentas; these bands represent two isoforms of MUC1 ( Fig. 2A) . In addition, our results showed that the third trimester placenta expressed significantly higher levels of MUC1 protein than did the first or second trimester placenta. Similar results showing an increase in MUC1 expression during placental development were also obtained by the use of another anti-MUC1 mAb, clone M2C5, which recognized isoforms different from VU4H5 (Fig. 2B) . The signals of VU4H5-and M2C5-reactive MUC1 on the representative immunoblots were quantified and shown in Figure 2C . Consistent with the MUC1 mRNA expression, our results demonstrate that MUC1 protein expression is increased during human placental development.
A) Quantitative RT-PCR showed that MUC1 mRNA expression in the human placenta was increased during placental development. The real-time RT-PCR signals of MUC1 were normalized to ACTB and analyzed with MxPro Software; n indicates the placenta number. Mann-Whitney U-test was used for statistical analyses of relative MUC1 mRNA expressions. Results are presented as mean 6 SD. **, P , 0.01; *, P 
MUC1 EXPRESSION IN THE HUMAN PLACENTA
Immunohistochemistry of MUC1 in Human Placental Villi
To investigate the localization of MUC1 protein in the human placenta, placentas from different gestational stages were analyzed by immunohistochemistry. We found that VU4H5-reactive forms of MUC1 were undetectable in first trimester placental villi (Fig. 3A) . In the second trimester, MUC1 was detected in syncytiotrophoblasts (Fig. 3B ). In the third trimester placenta, MUC1 could be easily found in syncytiotrophoblasts of most villi (Fig. 3C) . Immunohistochemistry with M2C5 showed similar results (Fig. 3, D-F) . Notably, MUC1 could be immunostained by M2C5 in the syncytiotrophoblasts of some placental villi (Fig. 3D) . A negative control that was stained by an irrelevant mouse IgG did not show any specific signals (Fig. 3F, inset) . No staining was found in stromal cells of placental villi. These results suggest that MUC1 in human placental villi is mainly expressed by syncytiotrophoblasts throughout pregnancy and is increased during placental development.
MUC1-Positive and MUC1-Negative Extravillous Trophoblasts Are Present in Human Decidua
To investigate the MUC1 expression in extravillous trophoblasts, decidua were analyzed by immunohistochemistry. Serial sections of decidua were immunostained by anti-KRT7 (Fig. 4A) or anti-MUC1 mAbs (Fig. 4B) . The representative image of second trimester decidua (23 wk gestation) stained by VU4H5 showed that two populations of extravillous trophoblasts, MUC1-positive and MUC1-negative cells, were present in the human decidua (Fig. 4) . Similar results were also found by the use of M2C5 (data not shown).
Our results also showed that extravillous trophoblasts were present in decidua throughout pregnancy, as revealed by KRT7 positive staining (Fig. 5 , A, C, and E). Interestingly, numbers of MUC1-positive extravillous trophoblasts stained by VU4H5 in decidua were increased during placental development (Fig.  5, B, D, and F) . Similar results were also found by the use of M2C5 (data not shown). In addition, MUC1 was highly expressed in glandular epithelia of the human decidua throughout pregnancy (Fig. 5D and data not shown) . These results indicate that two populations of extravillous trophoblasts, MUC1-positive and MUC1-negative cells, are present in the human decidua, and the numbers of MUC1-positive extravillous trophoblasts are increased during human placental development.
MUC1 Overexpression Suppresses Invasiveness of Trophoblast-Like JAR Cells
To investigate the effect of MUC1 expression on trophoblast invasion, matrigel invasion assays were performed in trophoblast-like JAR cells. JAR cells were transiently transfected with control plasmids (Mock) or MUC1-containing plasmids (MUC1) for 48 h and seeded into invasion chambers for another 48 h. The overexpression of MUC1 protein was confirmed by Western blotting with mAb M2C5 (Fig. 6A) . We found that MUC1 overexpression significantly (P , 0.01) decreased invasion of JAR cells by 34.6% 6 4.5% compared with control (Fig. 6B) . To further confirm that MUC1-high expressers exhibit less invasive ability than do MUC1-low expressers, the matrigel-coated filters in the invasion assays of MUC1-transfected cells were immunostained with anti-MUC1 mAb M2C5. The results showed that the percentage of MUC1-high expressers on the upper side of the filters was much higher than that on the lower side (Fig. 6C) . These results suggest that MUC1-high expressers indeed exhibit less invasive ability than do MUC1-low expressers in JAR cells.
Since MMP2 and MMP9 are the major metalloproteinases involved in trophoblast invasion, we therefore examined their enzyme activity by gelatin zymography. We found that MMP9 activity was suppressed by MUC1 overexpression (Fig. 6D) . However, MMP2 activity did not change. These results suggest that MUC1 overexpression suppresses invasion of trophoblast- 
DISCUSSION
The data from this study show that MUC1 mRNA and MUC1 protein increase with gestational stage of human pregnancy. MUC1 protein is mainly expressed by syncytiotrophoblasts in placental villi throughout pregnancy. In addition, we demonstrate that two populations of extravillous trophoblasts, MUC1-postive and MUC1-negative cells, are present in human decidua, and the numbers of MUC1-positive extravillous trophoblasts are increased during human placental development. Interestingly, MUC1 overexpression suppresses invasion of trophoblast-like JAR cells in vitro, which is associated with inhibition of MMP9 activity. Our results suggest that MUC1 is differentially expressed in the placenta and decidua during human placental development and may regulate extravillous trophoblast invasion in vitro.
We found that MUC1 expression in human placenta increases with gestational age. We could not detect significant MUC1 expression in placental villi unless a higher titer of MUC1 mAb was applied. In agreement with our findings, it has been observed that MUC1 expression is not found in the trophoblastic shell of early gestation macaque placental tissues [12] . Furthermore, the MUC1 expression by villous trophoblasts in these sections is often equivocal and weak at best. In contrast, Jeschke et al. [13] reported strong expression of MUC1 in human first and second trimester placentas. The reason for the controversy could be that Jeschke et al. analyzed MUC1 expression only by immunohistochemistry, in which protein signals cannot be quantitatively analyzed. In the present study, we analyzed both MUC1 mRNA and the MUC1 protein expression by quantitative RT-PCR, Western blot, and immunohistochemistry. In addition, similar results were obtained by the use of two anti-MUC1 mAbs, VU4H5 and M2C5, for Western blot and immunohistochemistry. It has been suggested that VU4H5 preferentially reacts with hypoglycosylated MUC1 [19] . In addition, M2C5 can detect underglycosylated and natural MUC1. In the present study, all results consistently demonstrate that both MUC1 mRNA and MUC1 protein expression increase with gestational stage. Therefore, we conclude that MUC1 expression in the placenta is increased during human placental development.
In the present study, we observed that two populations of extravillous trophoblasts, MUC1-positive and MUC1-negative cells, in decidua and the numbers of MUC1-positive extravillous trophoblasts are increased during human placental development. In addition, we demonstrate that MUC1 overexpression suppresses invasion of trophoblast-like JAR cells. These results suggest that MUC1 could be a negative regulator of trophoblast invasion and that MUC1-positive extravillous trophoblasts in decidua may exhibit less invasive ability than MUC1-negative extravillous trophoblasts in vivo. It is therefore reasonable to speculate that MUC1 could act as a MUC1 EXPRESSION IN THE HUMAN PLACENTA 237 restraint or brake in trophoblast invasion and could control the invasion of trophoblasts to an appropriate depth in the endometrium, which is essential for normal placental development. It will be of great interest to further investigate and distinguish the biological functions of these two types of extravillous trophoblasts in vivo. MMP2 and MMP9 are suggested to play an important role in trophoblast invasion during placental development [20] . Our results, for the first time, showed that MUC1 overexpression can inhibit MMP9 activity in vitro, suggesting that MUC1-suppressed invasion of trophoblast-like cells could partly result from the inhibition of MMP9 secretion. It is well known that MUC1 is able to transmit signals into the cell via its intracellular domain and, in turn, regulates various cell behaviors [4] . However, the signaling pathways regulating MMP9 secretion by MUC1 in trophoblast-like JAR cells remain unclear.
MUC1 has been found to be overexpressed by various types of tumors [4] . Many studies support that MUC1 overexpression enhances tumor cell invasion [21, 22] and promotes tumor malignancy [23] . In sharp contrast, we found that MUC1 overexpression suppresses invasion of trophoblast-like JAR cells in vitro. Interestingly, MUC15 can also suppress invasion of the trophoblast-like cells JAR and JEG-3 [14] . These results imply that the role of mucins in trophoblast-lineage cells in terms of invasion is different from that in other types of epithelia. The difference in MUC1 function in regulating cell invasiveness between trophoblast-like and other types of tumor cells may be a result of differential expression of certain cellular factors in trophoblast-like cells. The identity of these factors is under investigation in our laboratory.
Our data show that MUC1 is highly expressed by syncytiotrophoblasts in the term placenta. Muc1-null mice (Muc1 tm1Gend ) exhibit chronic infection and inflammation of the uterus as a result of increased infection by normal bacteria of the reproductive tract [8, 9] . In addition, MUC1 has been shown to protect cancer cells from immune cell attack [24] . Therefore, we speculate that MUC1 expression on the surface of syncytiotrophoblasts could protect the human placenta from microbial and immune cell attack. Furthermore, it has been found that MUC1 can interact directly with estrogen receptor alpha (ESR1) and epidermal growth factor receptor (EGFR) and regulate their signalings [25, 26] . It has been shown that estrogen, via interaction with the estrogen receptor, regulates functional differentiation of the syncytiotrophoblast in the primate placenta [27] . EGF, through interaction with EGFR, is able to regulate trophoblast apoptosis and Naþ/Hþ exchanger activity in the syncytiotrophoblast [28, 29] . Moreover, ESR1 and EGFR have been reported to be expressed by the human syncytiotrophoblast [30] [31] [32] . Therefore, it is interesting to investigate whether MUC1 can regulate the differentiation or biological functions of the syncytiotrophoblast through the regulation of ESR1 and EGFR signalings.
Recently, we reported that MUC15 expression in syncytiotrophoblasts increases with gestational age [14] , which is similar to the differential expression of MUC1 in placental villi during human placental development. However, MUC1, but not MUC15, is expressed in the sub-population of interstitial extravillous trophoblasts in the human decidua. These expression patterns suggest that MUC1 and MUC15 could exhibit similar but different functions during human placental development.
In conclusion, the present study reports the spatial and temporal expression of MUC1 in the human placenta throughout pregnancy. MUC1 expression in syncytiotrophoblasts and the numbers of MUC1-positive extravillous trophoblasts increase with gestational age during human placental development. In addition, MUC1 overexpression suppresses MMP9 activity and decreases invasion of trophoblast-like JAR cells. Based on these findings, we suggest that MUC1 could play a critical role in trophoblast invasion and may contribute to human placental development. For further investigation, it will be of great importance to study the role of MUC1 in pregnancy disorders, such as preeclampsia and intrauterine growth restriction, which are related to the dysfunction of trophoblast invasion and placental development.
